Loading…

Biological Production of Semisynthetic Opiates Using Genetically Engineered Bacteria

Semisynthetic derivatives of morphine and related alkaloids are in widespread clinical use. Due to the complexity of these molecules, however, chemical transformations are difficult to achieve in high yields. We recently identified the powerful analgesic hydromorphone as an intermediate in the metab...

Full description

Saved in:
Bibliographic Details
Published in:Bio/Technology 1995-07, Vol.13 (7), p.674-676
Main Authors: French, Christopher E, Hailes, Anne M, Rathbone, Deborah A, Long, Marianne T, Willey, David L, Bruce, Neil C
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Semisynthetic derivatives of morphine and related alkaloids are in widespread clinical use. Due to the complexity of these molecules, however, chemical transformations are difficult to achieve in high yields. We recently identified the powerful analgesic hydromorphone as an intermediate in the metabolism of morphine by Pseudomonas putida M10. Here we describe the construction of recombinant strains of Escherichia coli that express morphine dehydrogenase and morphinone reductase. These strains are capable of efficiently transforming the naturally occurring alkaloids morphine and codeine to hydromorphone and the antitussive hydrocodone, respectively. Our results demonstrate the potential for recombinant DNA technology to provide biological routes for the synthesis of known and novel semi-synthetic opiate drugs.
ISSN:0733-222X
1087-0156
2331-3684
1546-1696
DOI:10.1038/nbt0795-674